Annika I. Ostermann

2.3k total citations
33 papers, 1.0k citations indexed

About

Annika I. Ostermann is a scholar working on Biochemistry, Nutrition and Dietetics and Pathology and Forensic Medicine. According to data from OpenAlex, Annika I. Ostermann has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Biochemistry, 16 papers in Nutrition and Dietetics and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Annika I. Ostermann's work include Eicosanoids and Hypertension Pharmacology (25 papers), Fatty Acid Research and Health (16 papers) and Alcohol Consumption and Health Effects (11 papers). Annika I. Ostermann is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (25 papers), Fatty Acid Research and Health (16 papers) and Alcohol Consumption and Health Effects (11 papers). Annika I. Ostermann collaborates with scholars based in Germany, France and Hungary. Annika I. Ostermann's co-authors include Nils Helge Schebb, Ina Willenberg, Jan Philipp Schuchardt, Laura Kutzner, Andreas Hahn, Katharina M. Rund, Karsten H. Weylandt, Bruce D. Hammock, Jun Yang and Elisabeth Koch and has published in prestigious journals such as PLoS ONE, American Journal of Clinical Nutrition and Journal of Agricultural and Food Chemistry.

In The Last Decade

Annika I. Ostermann

33 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annika I. Ostermann Germany 18 608 408 289 244 123 33 1.0k
Laura Kutzner Germany 15 312 0.5× 269 0.7× 177 0.6× 80 0.3× 59 0.5× 22 606
Katharina M. Rund Germany 15 289 0.5× 192 0.5× 207 0.7× 85 0.3× 54 0.4× 23 619
Sean D. Kodani United States 19 556 0.9× 122 0.3× 241 0.8× 190 0.8× 118 1.0× 33 1.0k
Anne Konkel Germany 12 920 1.5× 536 1.3× 276 1.0× 299 1.2× 184 1.5× 17 1.3k
Marija Marković Serbia 12 480 0.8× 210 0.5× 205 0.7× 158 0.6× 114 0.9× 28 829
Catherine Calzada France 21 328 0.5× 510 1.3× 414 1.4× 67 0.3× 28 0.2× 57 1.5k
Halka Lotková Czechia 17 151 0.2× 48 0.1× 328 1.1× 128 0.5× 251 2.0× 43 1.0k
Egbert Scholtens Netherlands 23 186 0.3× 61 0.1× 351 1.2× 121 0.5× 287 2.3× 45 1.3k
Marta López‐Parra Spain 16 476 0.8× 554 1.4× 531 1.8× 77 0.3× 148 1.2× 22 1.8k
Takero Nakajima Japan 18 126 0.2× 97 0.2× 658 2.3× 67 0.3× 51 0.4× 50 1.3k

Countries citing papers authored by Annika I. Ostermann

Since Specialization
Citations

This map shows the geographic impact of Annika I. Ostermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annika I. Ostermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annika I. Ostermann more than expected).

Fields of papers citing papers by Annika I. Ostermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annika I. Ostermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annika I. Ostermann. The network helps show where Annika I. Ostermann may publish in the future.

Co-authorship network of co-authors of Annika I. Ostermann

This figure shows the co-authorship network connecting the top 25 collaborators of Annika I. Ostermann. A scholar is included among the top collaborators of Annika I. Ostermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annika I. Ostermann. Annika I. Ostermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saleh, Rasha N.M., Annette L. West, Annika I. Ostermann, et al.. (2021). APOE Genotype Modifies the Plasma Oxylipin Response to Omega-3 Polyunsaturated Fatty Acid Supplementation in Healthy Individuals. Frontiers in Nutrition. 8. 723813–723813. 15 indexed citations
2.
Koch, Elisabeth, C. Dalle, Annika I. Ostermann, et al.. (2020). Stability of oxylipins during plasma generation and long-term storage. Talanta. 217. 121074–121074. 40 indexed citations
3.
Ostermann, Annika I., Annette L. West, Lucy M. Browning, et al.. (2019). Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans. American Journal of Clinical Nutrition. 109(5). 1251–1263. 63 indexed citations
4.
Fischer, Jana, Annika I. Ostermann, Ina Willenberg, et al.. (2019). Impact of food polyphenols on oxylipin biosynthesis in human neutrophils. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1864(10). 1536–1544. 14 indexed citations
5.
Ostermann, Annika I., et al.. (2019). A strategy for validating concentrations of oxylipin standards for external calibration. Prostaglandins & Other Lipid Mediators. 141. 22–24. 12 indexed citations
6.
Dalle, C., Annika I. Ostermann, Cécile Coudy‐Gandilhon, et al.. (2018). Muscle Loss Associated Changes of Oxylipin Signatures During Biological Aging: An Exploratory Study From the PROOF Cohort. The Journals of Gerontology Series A. 74(5). 608–615. 15 indexed citations
7.
Ostermann, Annika I.. (2018). Development of Instrumental Analytical Methods for the Investigation of Omega-3 Fatty Acid Induced Effects on the Fatty Acid and Oxylipin Pattern. 1 indexed citations
8.
Rund, Katharina M., Annika I. Ostermann, Laura Kutzner, et al.. (2017). Development of an LC-ESI(-)-MS/MS method for the simultaneous quantification of 35 isoprostanes and isofurans derived from the major n3- and n6-PUFAs. Analytica Chimica Acta. 1037. 63–74. 69 indexed citations
9.
Schuchardt, Jan Philipp, et al.. (2017). Effect of DHA supplementation on oxylipin levels in plasma and immune cell stimulated blood. Prostaglandins Leukotrienes and Essential Fatty Acids. 121. 76–87. 29 indexed citations
10.
Ostermann, Annika I., et al.. (2017). A diet rich in omega-3 fatty acids enhances expression of soluble epoxide hydrolase in murine brain. Prostaglandins & Other Lipid Mediators. 133. 79–87. 15 indexed citations
11.
Ostermann, Annika I., Patrick Waindok, Cheng‐Ying Chiu, et al.. (2017). Modulation of the endogenous omega-3 fatty acid and oxylipin profile in vivo—A comparison of the fat-1 transgenic mouse with C57BL/6 wildtype mice on an omega-3 fatty acid enriched diet. PLoS ONE. 12(9). e0184470–e0184470. 33 indexed citations
12.
Schmöcker, Christoph, Ursula Kassner, Annika I. Ostermann, et al.. (2017). Effect of different lipid apheresis methods on plasma polyunsaturated fatty acids. Atherosclerosis Supplements. 30. 193–199. 5 indexed citations
13.
Schuchardt, Jan Philipp, et al.. (2016). Effects of docosahexaenoic acid supplementation on PUFA levels in red blood cells and plasma. Prostaglandins Leukotrienes and Essential Fatty Acids. 115. 12–23. 35 indexed citations
14.
Willenberg, Ina, Annika I. Ostermann, S. Giovannini, et al.. (2015). Effect of acute and chronic DSS induced colitis on plasma eicosanoid and oxylipin levels in the rat. Prostaglandins & Other Lipid Mediators. 120. 155–160. 8 indexed citations
15.
Willenberg, Ina, Annika I. Ostermann, & Nils Helge Schebb. (2015). Targeted metabolomics of the arachidonic acid cascade: current state and challenges of LC–MS analysis of oxylipins. Analytical and Bioanalytical Chemistry. 407(10). 2675–2683. 86 indexed citations
16.
Möller, Katharina, Annika I. Ostermann, Katharina M. Rund, et al.. (2015). Influence of weight reduction on blood levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and oxylipins in obese subjects. Prostaglandins Leukotrienes and Essential Fatty Acids. 106. 39–49. 40 indexed citations
17.
Willenberg, Ina, Annika I. Ostermann, Nils Helge Schebb, et al.. (2015). Impact of dextran sulphate sodium-induced colitis on the intestinal transport of the colon carcinogen PhIP. Archives of Toxicology. 90(5). 1093–1102. 5 indexed citations
18.
Ostermann, Annika I., Ina Willenberg, Rongjun Chen, et al.. (2015). Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern. Prostaglandins & Other Lipid Mediators. 121(Pt A). 131–137. 43 indexed citations
19.
Ostermann, Annika I., Ina Willenberg, & Nils Helge Schebb. (2014). Comparison of sample preparation methods for the quantitative analysis of eicosanoids and other oxylipins in plasma by means of LC-MS/MS. Analytical and Bioanalytical Chemistry. 407(5). 1403–1414. 89 indexed citations
20.
Schebb, Nils Helge, Annika I. Ostermann, Jun Yang, et al.. (2014). Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipins. Prostaglandins & Other Lipid Mediators. 113-115. 21–29. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026